- Oops!Something went wrong.Please try again later.
Mr. Meek will also join the Company's Board of Directors.
Earlier CEO Charles Baum led the Company for nine years.
Dr. Baum will continue to lead the research and development (R&D) organization as president, founder, and head of R&D and remain on the Company's Board of Directors.
David Meek most recently served as president, CEO, and board member of FerGene.
Price Action: MRTX stock is up 4.79% at $182.38 during the market session on the last check Monday.
See more from Benzinga
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.